One of Greater Cincinnati’s top-funded startups has reached a key sales milestone for its flagship product months after it was cleared for use by the U.S. Food and Drug Administration.
Blue Ash-based Standard Bariatrics, which is developing medical devices for surgical treatments of obesity, hit $1 million in sales in November for its Titan SGS, a surgical stapler approved by the FDA in April.
The Titan SGS was first used in gastric sleeve surgery Aug. 24, the company said. Since, it’s been used by bariatric surgeons across the country, including in Ohio, Kentucky, Michigan, California, Florida, Alabama and North Carolina.
The Titan SGS builds on Standard Bariatrics’ first commercial product, the standard clamp, a disposable device that can be used by surgeons performing laparoscopic sleeve gastrectomy, a common weight loss procedure. That was FDA-approved in 2017.
The Titan SGS features a first-of-its-kind design to help surgeons achieve more consistent and symmetrical gastric sleeve pouch anatomy, improving patient outcomes.
"In my 20-plus years of bariatric surgery, the Titan SGS is a game changer,” Dr. John Oldham, medical director of bariatrics for Baptist Health in Louisville, Ky., said in a release. “(The) sleeves are amazing; exactly how you would want them to look."
Standard Bariatrics was founded in 2014 by Dr. Jon Thompson, a UC Health surgeon who also established the Thompson Center at the University of Cincinnati Research Institute. The company most recently raised a $35 million Series B in June led by Silicon Valley-based U.S. Venture Partners and has raised $36.2 million to date, per Courier research.
Its investors include Queen City Angels, CincyTech and River Cities Capital locally as well as Hatteras Venture Partners and Emergent Medical Partners.
